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Abstract
Burkholderia pseudomallei and Burkholderia mallei are category B select agents and must be studied under BSL3
containment in the United States. They are typically resistant to multiple antibiotics, and the antibiotics used to treat B.
pseudomallei or B. mallei infections may not be used as selective agents with the corresponding Burkholderia species. Here,
we investigated alanine racemase deficient mutants of B. pseudomallei and B. mallei for development of non-antibiotic-
based genetic selection methods and for attenuation of virulence. The genome of B. pseudomallei K96243 has two
annotated alanine racemase genes (bpsl2179 and bpss0711), and B. mallei ATCC 23344 has one (bma1575). Each of these
genes encodes a functional enzyme that can complement the alanine racemase deficiency of Escherichia coli strain ALA1.
Herein, we show that B. pseudomallei with in-frame deletions in both bpsl2179 and bpss0711,o rB. mallei with an in-frame
deletion in bma1575, requires exogenous D-alanine for growth. Introduction of bpsl2179 on a multicopy plasmid into alanine
racemase deficient variants of either Burkholderia species eliminated the requirement for D-alanine. During log phase
growth without D-alanine, the viable counts of alanine racemase deficient mutants of B. pseudomallei and B. mallei
decreased within 2 hours by about 1000-fold and 10-fold, respectively, and no viable bacteria were present at 24 hours. We
constructed several genetic tools with bpsl2179 as a selectable genetic marker, and we used them without any antibiotic
selection to construct an in-frame DflgK mutant in the alanine racemase deficient variant of B. pseudomallei K96243. In
murine peritoneal macrophages, wild type B. mallei ATCC 23344 was killed much more rapidly than wild type B.
pseudomallei K96243. In addition, the alanine racemase deficient mutant of B. pseudomallei K96243 exhibited attenuation
versus its isogenic parental strain with respect to growth and survival in murine peritoneal macrophages.
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Introduction
Burkholderia pseudomallei and Burkholderia mallei are Gram-negative
bacteria that cause meliodosis in humans and glanders in horses,
respectively [1]. B. mallei is an equine pathogen [2,3] that
occasionally causes infections in humans. In contrast, B.
pseudomallei is frequently isolated from the environment in tropical
and subtropical areas [4,5], and it is transmitted to humans by
inhalation, ingestion, or direct contact [5]. The mortality rate for
acute cases of human melioidosis exceeds 40%, and a percentage
of the survivors may experience a relapse at a later time despite
previous antibiotic treatment and apparent cure [5,6].
Due to their ability to cause fatal infections, their intrinsic
antibiotic resistance, and the lack of an approved vaccine, B.
pseudomallei and B. mallei are considered to be potential
biological warfare agents and are classified as Category B select
agents in theUnited States (http://www.selectagents.gov/exclusions.
html#hhsAgents). Under current select agent guidelines, antibiotic
resistance markers cannot be used for experimental studies in B.
pseudomallei or B. mallei if they confer resistance to antibiotics used to
treat infections caused bythese bacteriain humans oranimals.To date,
only antibiotic resistance genes that confer resistance to gentamicin,
kanamycin, or zeocin are approved for use in B. pseudomallei,a n do n l y
genes that encode resistance to kanamycin or zeocin are approved for
use in B. mallei. Few genetic tools have been developed for use in
Burkholderia spp., and they typically employ the antibiotic resistance
genes described above as selectable markers [7,8,9,10,11,12]. Because
of these regulatory constraints, it is desirable to investigate the use of
non-antibiotic-based selectable markers for the development of
additional genetic tools for use in Burkholderia spp. Genes that encode
alanine racemase, a key enzyme for bacterial cell wall biosythesis, have
been used for this purpose in several other bacterial species.
Alanine racemases are pyridoxal 59 phosphate-containing,
homodimeric proteins that catalyze interconversion of L-alanine
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21523and D-alanine. D-alanine is an essential building block for
biosynthesis of peptidoglycan in bacterial cell walls, and it is also
found in lipotechoic acids of some Gram-positive bacteria [13,14].
Alanine racemases have been well-studied in several bacteria,
including Escherichia coli [15], Listeria monocytogenes [16], Mycobacte-
rium smegmatis [17], Pseudomonas putida [18], Salmonella enterica
serovar Typhimurium [19], Corynebacterium glutamicum [20,21],
Lactobacillus plantarum [22], and Bacillus spp. [23,24,25,26].
Bacterial genomes usually contain either one or two alanine
racemase genes. In bacteria with two alanine racemase genes, one
is typically expressed constitutively and used for D-alanine
biosynthesis, whereas the other is typically inducible and used
for catabolism of D-alanine [27,28,29,30]. In E. coli, alr encodes an
alanine racemase that is constitutively expressed and has apparent
anabolic activity, while dadX encodes an alanine racemase that is
involved in L-alanine catabolism [15,31]. A double knockout of
both dadX and alr is required to produce an E. coli auxotroph that
requires exogenous D-alanine for growth [31]. Bacteria that cannot
produce alanine racemase exhibit a conditional lethal phenotype
in the absence of exogenous D-alanine. An alanine racemase gene
can therefore function as a selectable genetic marker in an alanine
racemase deficient bacterial host growing in medium without
exogenous D-alanine. Genes that encode alanine racemase have
been used as an alternative to antibiotic resistance genes as
selectable genetic markers in alanine racemase deficient variants of
several bacterial species [20,32,33,34]. Additionally, an alanine
racemase deficient mutant of L. monocytogenes that exhibits defective
growth in phagocytic cells and reduced virulence in animals has
been investigated for potential use as a live attenuated vaccine
against L. monocytogenes [16].
The characteristics of alanine racemase deficient mutants of
Burkholderia spp. have not previously been evaluated. In this study,
we identified the genes that encode alanine racemase in B.
pseudomallei and B. mallei, constructed alanine racemase deficient
Figure 1. Alignment of amino acid sequences of alanine racemases from B. pseudomallei (BPSL2179 and BPSS0711), B. mallei
(BMA1575), B. thailandensis (BTH_I2007 and BTH_II1715), E. coli (EcoliDadX and EcoliAlr), and P. aeruginosa (PAO1DadX and
PAO1Alr). Residues that are identical in all of these alanine racemase enzymes are shown with a black background. Residues that are identical in 7 or
8 of these enzymes are shown with a dark grey background, and residues that are identical in 5 or 6 of these enzymes are shown with a light grey
background.
doi:10.1371/journal.pone.0021523.g001
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alanine racemase deficient mutants of both species for growth and
viabilityinthepresenceandabsenceofexogenous D-alanine,bothin
vitro and in murine peritoneal macrophages. Furthermore, we
developed genetic tools with selectable alanine racemase markers to
perform allelic exchange and gene complementationexperiments in
alanine racemasedeficienthoststrains ofB.pseudomalleiandB.mallei.
Finally, as proof of principle, we used these tools to construct an in-
frame deletion in the flgK gene of B. pseudomallei and to complement
the flgK mutant with a wild type flgK
+ allele on a replicating plasmid,
thereby avoiding the need for antibiotics as selective agents.
Results
Identification of genes in B. pseudomallei and B. mallei
that encode alanine racemases
Analysis of the genome sequence of B. pseudomallei strain K96243
[35] revealed two putative alanine racemase genes: bpsl2179 on
chromosome 1 which encodes a 356 amino acid protein, and
bpss0711 on chromosome 2 which encodes a 374 amino acid
protein. Analysis of the genome sequence of B. mallei ATCC 23344
[36] revealed a single putative alanine racemase gene, designated
bma1575. The coding sequences for bma1575 and bpsl2179 differ by
only 3 nucleotides, and they encode identical proteins. We did not
find a homologue of bpss0711 in the genome sequence of B. mallei
ATCC 23344. Figure 1 compares and aligns the predicted amino
acid sequences for these putative alanine racemases from B.
pseudomallei and B. mallei with the two reported alanine racemases
per species from Burkholderia thailandensis, E. coli and Pseudomonas
aeruginosa [37,38,39]. The identical proteins encoded by bpsl2179
from B. pseudomallei and bma1575 from B. mallei have 73% amino
acid sequence similarity with the protein encoded by bpss0711from
B. pseudomallei and 60–99% amino acid sequence similarity with the
other alanine racemases shown in Figure 1.
We used genetic complementation tests in E. coli to demonstrate
that bpsl2179 and bpss0711 from B. pseudomallei encode functional
alanine racemases. Toward that end, we first constructed an alanine
racemase deficient strain of E. coli, called ALA1, as described in
Materials and Methods. E. coli ALA1 was unable to grow on LB
agar or in LB broth unless D-alanine was added at $1 mM. In
contrast, the parental strain of E. coli did not require added D-
alanine for growth. When E. coli ALA1 was grown overnight at
37uC in LB broth with D-alanine and washed bacteria were sub-
cultured in LB broth with or without D-alanine, the bacteria
resumed normal growth in the LB broth with D-alanine, but they
failed to grow and viability decreased progressively by about
1,000,000-fold over 8 hours in the LB broth without D-alanine (data
not shown). Finally, introducing plasmid pET17alrintoE. coli ALA1
restored the ability of E. coli ALA1 to grow in LB medium without
added D-alanine. These findings demonstrate that E. coli ALA1 is
auxotrophic for D-alanine and provide genetic evidence that it does
not produce functional alanine racemase. Next, we constructed
plasmids containing bpsl2179 or bpss0711 from B. pseudomallei
(designated pCR2.1-TOPOH -bpsl2179 and pCR2.1-TOPOH-
bpss0711, respectively) and transformed them individually into E.
coli ALA1. At 37uC on LB agar without D-alanine, visible growth of
E. coli ALA1(pCR2.1-TOPOH -bpsl2179) transformants was
detected after 15 hours, and visible growth of E. coli
ALA1(pCR2.1-TOPOH-bpss0711) transformants was detected after
24 hours. We constructed a second bpss0711 clone with a longer
upstream sequence (Tables 2 and 3), designated pCR2.1-TOPOH-
bpss0711-F2, and demonstrated that the growth of E. coli
ALA1(pCR2.1-TOPOH-bpss0711-F2) transformants on LB agar
without D-alanine was comparable to that of E. coli ALA1(pCR2.1-
TOPOH -bpsl2179) transformants. We did not investigate further
the molecular basis for the different properties of the pCR2.1-
TOPOH-bpss0711 and pCR2.1-TOPOH-bpss0711-F2 clones. We
also showed that a pCR2.1-TOPOH-bma1575 clone from B. mallei
was able to complement the alanine racemase deficiency of E. coli
ALA1. In contrast, the E. coli ALA1(pCR2.1-TOPOH) vector
control did not grow under these conditions. Taken together, these
genetic data demonstrate that bpsl2179, bpss0711,a n dbma1575
encode functional alanine racemase proteins.
Construction and characterization of B. pseudomallei and
B. mallei alanine racemase deficient mutants
The arrangements of the bpsl2179 locus in the large chromo-
some and the bpss0711 locus in the small chromosome of B.
Figure 2. Organization of the bpsl2179 and bpss0711 loci in the large and small chromosome, respectively, of Burkholderia
pseudomallei K96243. Panel A and Panel B show the relationship of the wild type bpsl2179 and bpss0711 alleles to their contiguous upstream and
downstream genes. Panel C and Panel D show the locations and relative sizes of the in-frame deletion variants Dbpsl2179 and and Dbpss0711,
respectively, constructed in this study. The alanine racemase gene (bma1575)o fB. mallei is contained within a region similar to that of the bpsl2179
allele of B. pseudomallei shown in Panel A.
doi:10.1371/journal.pone.0021523.g002
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Fig. 2B, respectively. Both bpsl2179 and bpss0711 are predicted to
be transcribed as single genes. The chromosomal loci carrying the
corresponding Dbpsl2179 and Dbpss0711 in-frame deletion alleles
described below are shown schematically in Fig. 2C and Fig. 2D,
respectively.
We used in vitro methods to construct mutant alleles, designated
Dbpsl2179 and Dbpss0711, with in-frame deletions corresponding
to 99% of the coding regions of bpsl2179 and bpss0711,
respectively. These mutant alleles were substituted, either singly
or together, for the corresponding wild type alleles in the
chromosomes of B. pseudomallei strain K96243 and B. pseudomallei
strain 1026b by using the pMo130 allelic exchange system
previously described [12]. In both of these B. pseudomallei strains,
the resulting single mutants carrying either Dbpsl2179 or
Dbpss0711 grew normally on LB agar without added D-alanine,
but the Dbpsl2179/Dbpss0711 double mutant required exogenous
D-alanine for growth. Fig. 3 illustrates the patch tests that we used
to distinguish individual resolved co-integrants with the
Dbpsl2179/Dbpss0711 double mutant genotype that grow only
on LB agar containing D-alanine from individual resolved co-
integrants with the Dbpsl2179 single mutant genotype that do not
require D-alanine for growth. Our results showed that a single wild
type allele of either bpsl2179 or bpss0711 is sufficient for normal
growth of B. pseudomallei on LB agar without added D-alanine, and
they showed that no gene except bpsl2179 or bpss0711 directs
production of functional alanine racemase in B. pseudomallei strain
K96243 or strain 1026b. In contrast, a single in-frame deletion at
the bma1575 locus of B. mallei ATCC 23344, introduced by allelic
exchange using the highly homologous pMo130D bpsl2179 clone,
conferred a stringent growth requirement for exogenous D-alanine.
This finding indicates that bma1575 is the only gene in B. mallei
ATCC 23344 that directs production of alanine racemase. The
presence of the appropriate wild type or in-frame deletion variant
of bpsl2179 or bpss0711 in each newly constructed mutant was
confirmed by PCR using primers located upstream and down-
stream of the appropriate gene, as illustrated in Fig. 4. For all
subsequent experiments, the term ‘‘alanine racemase deficient
mutants’’ refers to a Dbpsl2179/Dbpss0711 double mutant for B.
pseudomallei strain K96243 or B. pseudomallei strain 1026b, and to a
Dbma1575 single mutant for B. mallei strain ATCC 23344.
To demonstrate complementation of the functional defect in the
alanine racemase deficient mutants of B. pseudomallei and B. mallei,
the wild type bpsl2179 gene was first cloned into the replicative
plasmid pMo168 [12] in place of the aphA cassette, yielding pALR-
comp. The pALR-comp plasmid was then introduced by
conjugation into the alanine racemase deficient mutant strains of
B. pseudomallei K96243, B. pseudomallei 1026b, and B. mallei ATCC
23344. Transconjugant colonies were recovered on LB agar
containing zeocin or polymyxin B. The presence of pALR-comp
in transconjugant colonies was confirmed by detecting the XylE
reporter enzyme encoded by pALR-comp, and complementation of
the alanine racemase deficiency was confirmed by the ability of the
transconjugants to grow with or without the addition of D-alanine.
To determine the minimal concentration of D-alanine necessary
to support growth of the Burkholderia alanine racemase deficient
mutants, samples from log phase cultures of each mutant, wild
type, or complemented strain were spread onto LB agar with D-
alanine at various concentrations from 0 to 10 mM, and the plates
were inspected for bacterial growth during subsequent incubation
at 37uC. Fig. 5 shows the results for the B. pseudomallei K96243-
derived strains. After 24–36 hr, the wild type parental strain
(Fig. 5A) and the complemented mutant (Fig. 5C) showed heavy
confluent growth on medium without D-alanine. In contrast, the
Dbpsl2179/Dbpss0711 mutant showed no growth on medium
without D-alanine, scattered colonies on medium with 1.25 mM D-
alanine, sub-confluent growth on medium with 2.5 mM D-alanine,
and confluent growth on medium with 5 or 10 mM D-alanine
Figure 4. PCR confirmation of deletions in Dbpsl2179 and
Dbpss0711 mutants of B. pseudomallei. Primers BPSL2179-up and
BPSL2179-down were used to generate a 3108 bp fragment from
strains carrying the wild type bpsl2179 allele or a 2100 bp fragment
from stains carrying the Dbpsl2179 allele. Primers BPSS0711-up and
BPSS0711-down were used to generate a 3247 bp fragment from
strains carrying the wild type bpss0711 allele or a 2188 bp fragment
from strains carrying the Dbpss0711 allele. Lane labels and samples
analyzed are as follows: MW, DNA ladder; Dbpss0711, amplicon from
strain carrying the Dbpsl2179 mutant allele; bpss0711, amplicon from
strain carrying the wild type bpss0711 allele; Dbpsl2179, amplicon from
strain carrying the Dbpsl2179 mutant allele; and bpsl2179, amplicon
from strain carrying the wild type bpsl2179 allele.
doi:10.1371/journal.pone.0021523.g004
Figure 3. Screening of resolved co-integrants during construc-
tion of a Dbpsl2179/Dbpss0711 double mutant of B. pseudomallei.
Individual colonies of resolved co-integrants were picked from YT agar
plates containing 15% sucrose and 10 mM D-alanine and inoculated in
patches at comparable locations on LB agar plates with and without
10 mM D-alanine. Resolvants with the Dbpsl2179/Dbpss0711 genotype
grew only on the LB agar with D-alanine, and resolvants with the
Dbpsl2179 genotype grew on LB agar with or without D-alanine.
doi:10.1371/journal.pone.0021523.g003
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mutant and complemented strains derived from B. pseudomallei
1026b and B. mallei ATCC 23344 (data not shown). It is
noteworthy that the concentration of D-alanine needed to support
growth of the alanine racemase deficient mutants of B. pseudomallei
and B. mallei was significantly greater than the concentration of D-
alanine required to support growth of E. coli ALA1.
To assess the effects of D-alanine deprivation on growth and
viability of the wild type and alanine racemase deficient variants of
B. pseudomallei and B. mallei as a function of time, we collected
bacteria from cultures grown overnight in LB broth containing
10 mM D-alanine, washed the bacteria with LB broth, and
transferred inocula into LB broth subcultures with or without
10 mM D-alanine. We measured turbidity and viable counts in
samples taken periodically from each subculture during the first
seven hours (Fig. 6) and again at 24 hours. The alanine racemase
deficient mutants of B. pseudomallei K96243 and B. mallei ATCC
23344 exhibited growth arrest in LB broth without D-alanine
(Fig. 6A and Fig. 6C), but the growth of each mutant in LB broth
with D-alanine was comparable to the growth of its wild type
parental strain in LB broth with or without D-alanine. Under the
conditions that permitted growth, the doubling time for the wild
type and mutant B. mallei strains was about 48 minutes, and the
doubling time for the wild type and mutant B. pseudomallei strains
was about 36 minutes. Furthermore, each alanine racemase
deficient mutant, but not its isogenic parental strain, lost viability
progressively with increasing incubation time in the LB broth
without D-alanine (Fig. 6B and Fig. 6D). During the first two hours
without D-alanine, the alanine racemase deficient mutant of B.
pseudomallei K96243 lost viability more rapidly than the alanine
racemase deficient mutant of B. mallei strain ATCC 23344 (,4
log10 decrease vs. ,1 log10 decrease, respectively). After 7 hours
without D-alanine, viability declined by about 5 log10 for both of
the alanine racemase deficient mutants. After 24 hours without D-
alanine, no viable bacteria were recovered from cultures of either
of the alanine racemase deficient mutants (data not shown).
Results with the wild type and alanine racemase deficient mutant
of B. pseudomallei 1026b were comparable to those shown above for
the wild type and alanine racemase deficient mutant of B.
pseudomallei K96243, respectively (data not shown).
Figure 5. Determination of D-alanine concentration needed to support growth of the Dbpsl2179/Dbpss0711 alanine racemase
deficient mutant of B. pseudomallei K96243 on LB agar medium. Overnight cultures of the wild type, Dbpsl2179/Dbpss0711 mutant, and
Dbpsl2179/Dbpss0711 mutant complemented with pALR-comp were inoculated into LB broth containing 10 mM D-alanine. Cultures were grown to
an OD600 nm=0.2 and plated onto LB agar without D-alanine (0 mM) or with D-alanine at concentrations from 1.25 mM to 10 mM as indicated. Panel
A: B. pseudomallei K96243. Panel B: The Dbpsl2179/Dbpss0711 mutant of B. pseudomallei K96243. Panel C.: The Dbpsl2179/Dbpss0711 mutant of B.
pseudomallei K96243 complemented with plasmid pAlr-comp. Comparable results were obtained with isogenic wild type, alanine racemase deficient,
and complemented alanine racemase deficient strains of B. pseudomallei 1026b and B. mallei ATCC 23344 (data not shown).
doi:10.1371/journal.pone.0021523.g005
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deficient mutants of B. pseudomallei or B. mallei can recover from D-
alanine deprivation for varying periods of time, we grew each
mutant overnight in LB broth containing 10 mM D-alanine and
then transferred washed bacteria into six identical subcultures
containing LB broth alone. At time 0, 30, 60, 90, and 120 minutes
post inoculation, 10 mM D-alanine was added to separate
subcultures, and the sixth subculture served as a control without
added D-alanine. Samples were withdrawn from each subculture
periodically for a total of 7 hours, and each sample was examined
for turbidity and viable counts (Fig. 7). For the alanine racemase
deficient mutant of B. pseudomallei strain K96243, growth resumed
after a few minutes when D-alanine was added back to the cultures
at 30 or 60 minutes (Fig. 7A). In contrast, D-alanine deprivation
for 90 minutes caused a lag period of at least 2 hours before
growth resumed, and D-alanine deprivation for 120 minutes
caused growth arrest to the end of the 7-hour observation period
(Fig. 7A). D-alanine deprivation for 30 or 60 minutes did not cause
a substantial decrease in viability of the alanine racemase deficient
mutant of B. pseudomallei strain K96243 (Fig. 7B). In contrast,
90 minutes of D-alanine deprivation resulted in ,1 log10 decrease
in viability, and 120 minutes of D-alanine deprivation caused ,3
log10 decrease in viability. Bacteria that were viable after each
period of D-alanine deprivation resumed growth shortly after D-
alanine was added back to the medium. Similar results were
obtained with the alanine racemase deficient mutant of B.
pseudomallei strain 1026b (data not shown). For the alanine
racemase deficient mutant of B. mallei, prolonged growth
retardation and a transient decrease in viability occurred with D-
alanine deprivation for 120 minutes but not with D-alanine
deprivation for 90 minutes or less (Figs. 7C and 7D).
Intracellular survival of wild type and alanine racemase
deficient strains of B. pseudomallei and B. mallei in
periodate-elicited murine peritoneal macrophages
B. pseudomallei is able to survive in non-phagocytic cells and
phagocytic cells [40] and B. mallei can survive in macrophages
[41]. Due to the rapid decrease in viability of the alanine racemase
deficient mutants under conditions of D-alanine deprivation and
Figure 6. Alanine racemase deficient mutants of B. pseudomallei and B. mallei grew normally in LB broth with 10 mM D-alanine, but
they exhibited growth arrest and rapidly lost viability in LB broth without D-alanine. In contrast, the isogenic parental strains of B.
pseudomallei and B. mallei grew normally in LB broth either with or without added D-alanine. In each panel, a closed square (&) represents the wild
type strain grown in the presence of D-alanine; an open square (%) represents the wild type strain grown without D-alanine; a closed circle (N)
represents the alanine racemase deficient mutant grown in the present of D-alanine; and an open circle (#) represents the alanine racemase deficient
mutant grown without D-alanine. Panel A: Turbidity of cultures of wild type and mutant strains of B. pseudomallei K96243. Panel B: Viability of bacteria
in cultures of wild type and mutant strains of B. pseudomallei K96243. Panel C: Turbidity of cultures of wild type and mutant strains of B. mallei ATCC
23344. Panel D: Viability of bacteria in cultures of wild type and mutant strains of B. mallei ATCC 23344. Results with wild type and mutant strains of B.
pseudomallei 1026b (not shown) were similar to those obtained with wild type and mutant strains of B. pseudomallei K96243.
doi:10.1371/journal.pone.0021523.g006
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normal growth of these mutants, we tested whether the alanine
racemase deficient mutant strains of B. pseudomallei and B. mallei
would exhibit decreased survival in phagocytic cells in comparison
with their isogenic parental strains. First, we infected murine
peritoneal macrophages with wild type or alanine racemase
deficient strains of B. pseudomallei K96243. Bacteria were added to
the macrophage cultures in RPMI
+ medium supplemented
with 5 mM D-alanine, and the infected cultures were incubated
for 3 hours to permit phagocytosis of B. pseudomallei. The cultures
were then washed with media containing kanamycin plus or minus
5m M D-alanine, and the viable intracellular bacteria were
enumerated at times 0, 3, 4, and 5-hours in sets of 5 replicate
cultures. The % survival was expressed as (cfu at tn/cfu at t0)
6100. For wild type B. pseudomallei K96243, survival of
intracellular bacteria was approximately 1% after 5 hours, and
survival was not affected by the presence or absence of 5 mM D-
alanine in the culture medium (Fig. 8A). In contrast, intracellular
survival of the alanine racemase deficient mutant of B. pseudomallei
K96243 after 5 hours in medium without D-alanine was only
0.01%, compared to about 0.5% in medium containing 5 mM D-
alanine (Fig. 8B). To confirm the internalization of the wild type
and mutant bacteria, we collected macrophages after the initial 3-
hour period of contact with bacteria and analyzed them by
transmission electron microscopy (Fig. 9). Comparable numbers of
intracellular bacteria were observed for the wild type and mutant
bacterial strains (Fig. 9, Panels A and B). Taken together, these
findings demonstrate a substantially decreased ability of the
alanine racemase deficient mutant of B. pseudomallei K96243 to
survive within murine peritoneal macrophages unless a high
concentration of D-alanine was present during the killing assay.
Next, we compared the wild type and alanine racemase
deficient strains of B. mallei in macrophage killing assays. Murine
peritoneal macrophages were infected with the wild type or
alanine racemase deficient mutant strain of B. mallei ATCC23344
under conditions similar to those described above for B.
Figure 7. Ability of alanine racemase deficient mutants of B. pseudomallei or B. mallei to recover from varying periods of D-alanine
deprivation. The alanine racemase deficient mutants of B. pseudomallei K96243 and B. mallei ATCC 23344 were grown overnight in LB broth
containing 10 mM D-alanine. Inocula from each culture were transferred into sets of six replicate subcultures in LB broth. Supplemental D-alanine at a
final concentration of 10 mM was added to separate LB broth subcultures of each mutant at 0, 30, 60, 90, or 120 minutes post-inoculation,
respectively, and the final subculture received no added D-alanine. Culture turbidity (OD600 nm) and viability was measured for each subculture
periodically up to 420 minutes. In each panel, an open circle (#) represents the subculture without added D-alanine; a closed circle (N) represents of
the subculture with D-alanine added at time zero; a closed square (&) represents the subculture with D-alanine after added at 30 min; an open square
(%) represents the subculture with D-alanine added at 60 min; a closed triangle (m) represents the subculture with D-alanine added at 90 min; and an
open triangle (n) represents the subculture with D-alanine added at 120 min. Panel A; Turbidity of subcultures of the alanine racemase deficient
mutant of B. pseudomallei K96243. Panel B: Viable counts in subcultures of the alanine racemase deficient mutant of B. pseudomallei K96243. Panel C:
Turbidity of subcultures of the alanine racemase deficient mutant of B. mallei ATCC 23344. Panel D: Viable counts in subcultures of the alanine
racemase deficient mutant of B. mallei ATCC 23344. Results for the alanine racemase deficient mutant of B. pseudomallei K96243 are comparable to
the results obtained with the alanine racemase deficient mutant of B. pseudomallei 1026b (data not shown).
doi:10.1371/journal.pone.0021523.g007
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mented RPMI
+ medium, the macrophages were washed with pre-
warmed RPMI
+ medium containing 6 mg/ml gentamicin with or
without 5 mM D-alanine. Electron microscopy demonstrated
comparable numbers of wild type and mutant bacteria within
macrophages immediately after the 2-hour phagocytosis phase of
the killing assays (Fig. 9, Panels C and D). Survival of the
intracellular bacteria was determined after an additional 4 hours
of incubation. In contrast to the previous results for B. pseudomallei,
both wild type B. mallei and the isogenic alanine racemase deficient
mutant were equally susceptible to killing by macrophages, and
enhanced killing of the alanine racemase deficient mutant was not
observed in medium without D-alanine (Fig. 10). In conclusion, the
alanine racemase deficient mutant of B. mallei did not exhibit an
increased susceptibility to intracellular killing in macrophages
under these experimental conditions.
The use of alanine racemase as a selectable genetic
marker
To demonstrate the use of alanine racemase as selectable
genetic marker for construction of mutant strains of Burkholderia
spp., we first replaced the aphA gene in the allelic exchange vector
pMo130 [12] with bpsl2179 from B. pseudomallei K96243 to
generate pAlr-allex. Then, as proof of principle, we used the pAlr-
allex vector system to construct a DflgK mutant without use of
antibiotics for selection. This experiment was based on results of a
previous study demonstrating that deletion of flgK, which encodes
the flagellar protein FlgK, causes loss of motility in B. pseudomallei
[12]. By cloning DflgK from pMo146 [12] into pAlr-allex, we
targeted the flgK gene of B. pseudomallei for deletion. The resulting
plasmid designated pAlr-allex-DflgK was introduced by conjuga-
tion into the alanine racemase deficient B. pseudomallei strains
K96243 Dbpss0711/Dbpsl2179 and 1026b Dbpss0711/Dbpsl2179.
Transconjugants were selected by growth on LB agar medium
without added D-alanine and confirmed by detection of XylE
activity. Following counter-selection on sucrose, some of the
resolved transconjugants of B. pseudomallei strains K96243 and
1026b exhibited both a loss of motility and a growth requirement
for D-alanine, consistent with their DflgKDbpss0711Dbpsl2179
genotypes (data not shown).
Figure 8. Survival of wild type and isogenic alanine racemase
deficient mutant strains of B. pseudomallei within murine
macrophages. A) Survival of wild type B. pseudomallei K96243 in
murine macrophages in RPMI
+ medium containing 250 mg/ml of
kanamycin with (&) or without (%)5m MD-alanine. B) Survival of
the isogenic alanine racemase deficient mutant strain Dbpsl2179/
Dbpss0711 in murine macrophages in RPMI
+ medium containing
250 mg/ml of kanamycin with (&) or without (%)5m MD-alanine.
doi:10.1371/journal.pone.0021523.g008
Figure 9. Phagocytosis of wild type and isogenic alanine
racemase deficient mutant strains of B. pseudomallei and B.
mallei by murine macrophages. Immediately after the phagocytosis
phase of macrophage killing assays, the macrophages were fixed and
examined by transmission electron microscopy for the presence of
intracellular bacteria. A) Wild type B. pseudomallei K96243; B) Isogenic
alanine racemase deficient B. pseudomallei K96243; C) Wild type B.
mallei ATCC 23344; D) Isogenic alanine racemase deficient B. mallei
ATCC 23344.
doi:10.1371/journal.pone.0021523.g009
Figure 10. Survival of wild type and isogenic alanine racemase
deficient mutant strains of B. mallei within murine macrophag-
es. Murine peritoneal periodate-elicited macrophages were infected in
vitro with wild type or alanine racemase deficient mutant strains of B.
mallei. After 2 h of phagocytosis in D-alanine-supplemented RPMI
+
medium, the macrophages were washed with prewarmed RPMI
+
medium containing 6 mg/ml gentamicin with or without 5 mM D-
alanine. The surviving intracellular bacteria were enumerated after 4 h
of culture. The % survival was enumerated by (cfu tn/cfu t0)100.
doi:10.1371/journal.pone.0021523.g010
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marker for complementation tests, we cloned the wild type flgK
+
allele into pAlr-comp and introduced the resulting pAlr-comp-
flgK
+ plasmid by conjugation into the DflgK/Dbpss0711/Dbpsl2179
mutants of B. pseudomallei strains K96243 and 1026b described
above. Transconjugants were selected by growth on LB agar
medium lacking D-alanine and confirmed by detection of XylE
activity. Introduction of pAlr-comp-flgK
+ into these non-motile
mutants of B. pseudomallei restored motility to wild type levels in
addition to restoring the ability of the mutants to grow without
added D-alanine (data not shown). These experiments using pAlr-
allex and pAlr-comp established proof of principle that alanine
racemase can be used as a selectable marker for construction of in-
frame mutants by allelic exchange and for in trans complementa-
tion in pathogenic Burkholderia spp.
Discussion
In the United States, the study of B. pseudomallei and B. mallei is
highly regulated because they are classified as category B select
agents. Furthermore, few antibiotic resistance determinants are
approved as selectable markers for use in genetic studies of B.
pseudomallei and B. mallei [5,42]. Previous studies have identified
several non-antibiotic selectable markers for use in genetic studies
of bacteria. Most are based on the lethal consequences of
inactivating an essential gene, and preserving viability by
providing a wild type allele of the inactivated essential gene to
complement the lethal phenotype. One such system used a thyA
mutant of Lactococcus lactis that cannot survive without an
exogenous source of thymidine or thymine unless thyA
+ is
introduced on a replicating plasmid or by another genetic method
[43,44]. In Salmonella enterica serovar Typhimurium and P. aeruginosa,
a comparable system was based on inactivation of the asd gene
encoding aspartate b-semialdehyde dehydrogenase, an enzyme
required for diaminopimelic acid production and peptidoglycan
synthesis in these bacterial species [45,46]. Without diaminopi-
melic acid, asd mutants will lyse, whereas asd mutants comple-
mented with an asd
+ allele will survive and grow normally. In C.
glutamicum and L. monocytogenes [20,33,34], inactivation of the gene
encoding alanine racemase, an enzyme required for production of
D-alanine and for peptidoglycan biosynthesis, was shown to be
lethal unless D-alanine was added to the growth medium or the
genetic defect was complemented by the presence of a wild type
allele of the alanine racemase gene.
In the present study, we constructed and characterized alanine
racemase mutants of B. pseudomallei and B. mallei and demonstrated
that they exhibit a stringent requirement for exogenous D-alanine
for growth and viability. In B. pseudomallei, it was necessary to
inactivate both bpsl2179 and bpss0711 to produce an alanine
racemase deficient phenotype, whereas in B. mallei inactivation of
bma1575 alone was sufficient to produce an alanine racemace
deficient phenotype. Other bacterial species whose genomes
encode two different but functional alanine racemases include
S. enterica serovar Typhimurium, P. aeruginosa, and E. coli
[19,27,47,48,49]. In contrast, C. glutamicum [20] and Lactobacillus
plantarum [22] are representative of bacterial species whose
genomes encode only one functional alanine racemase.
In this study, we showed that a gene encoding alanine racemase
can be used effectively as a selectable marker for genetic
manipulations in alanine racemase deficient parental strains of
pathogenic Burkholderia spp. We constructed an allelic exchange
vector with a selectable alanine racemase gene and used it to
generateaDflgK mutation intwodifferent alanine racemasedeficient
reference strains of B. pseudomallei. In addition, we constructed a
replicative plasmid carrying wild type alleles of the alanine racemase
gene bpsl2179 and the flgK gene and showed that it could
complement the DflgK mutation in an alanine racemase deficient
strain and restore its ability to grow in the absence of exogenous D-
alanine. The pAlr-allex and pAlr-comp plasmids described in this
study are significant additions to the current repertoire of tools for
use in genetic studies of pathogenic Burkholderia spp.
We also demonstrated that an alanine racemase deficient
mutant of B. pseudomallei K96243 lost viability at a much faster rate
than its isogenic parental strain in murine peritoneal periodate-
elicited macrophages growing in cell culture medium without
added D-alanine. However, the addition of 5 mM D-alanine to the
cell culture medium allowed the alanine racemase deficient
mutant to survive intracellularly as well as its wild type parental
strain. In another published study, an alanine racemase deficient
(dal dat) mutant of L. monocytogenes also exhibited growth attenuation
in macrophages and required exogenous D-alanine in the culture
medium to achieve levels of intracellular survival comparable to
the wild type parental strain [16]. L. monocytogenes lacking alanine
racemase failed to elicit an immune response in mice when it was
inoculated without added D-alanine. In contrast, when it was
inoculated together with D-alanine, the mice developed a
protective immune response and survived a subsequent challenge
with a dose of wild type L. monocytogenes that was lethal for un-
immunized mice [16]. The authors proposed that the addition of
D-alanine enabled the attenuated strain to undergo limited
replication in the inoculated mice that was sufficient to elicit a
protective immune response [16]. They also showed that few
viable bacteria remained in the mouse tissues after 1–2 days [16],
presumably because depletion of the inoculated D-alanine by D-
amino acid oxidases of the mouse [50,51,52,53,54] resulted in
rapid death of the inoculated bacteria and their progeny. Our
alanine racemase deficient mutant of B. mallei did not exhibit
attenuation under the conditions used for our experiments.
Because wild type B. mallei grows more slowly than B. pseudomallei
and is killed more rapidly than B. pseudomallei in macrophages, it
seems likely that the B. mallei mutant did not grow enough within
the macrophages to permit D-alanine deprivation to contribute
significantly to the overall loss of viability. Since there is currently
no vaccine for B. pseudomallei or B. mallei, the use of an attenuated
strain as a potential vaccine is appealing. Additional studies will be
needed to examine the degree of attenuation of our alanine
racemase deficient mutants of B. pseudomallei and B. mallei in
normal and immunocompromised animals and to test their ability
to stimulate protective immune responses after they are inoculated
with or without added D-alanine, as described above for alanine
racemase deficient mutants of L. monocytogenes. Such experiments
are beyond the scope of this study and will require animal facilities
approved for use with select agents that are not available at our
institution. Recently, Propst et al. [55] reported that a DpurM
mutant of B. pseudomallei is attenuated both in immunocompetent
and immunodeficient animals and could be considered for possible
exclusion from select agent classification. Additional studies will be
needed to demonstrate whether alanine racemase deficient
mutants of B. pseudomallei and B. mallei may also be appropriate
candidates for possible exclusion from select agent classification.
Strongly attenuated mutants of Bacillus anthracis, Brucella abortus,
Coxiella burnetii, Francisella tularensis, and Yersinia pestis have already
been excluded from select agent classification (http://www.
selectagents.gov/exclusions.html#hhsAgents) [55].
There are many ways that purine- or D-alanine requiring
mutants such as those described above could be used to facilitate
future genetic studies with B. pseudomallei or B. mallei. Possible
exclusion from select agent classification would enable such strains
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rather than BSL3 containment. This would greatly simplify the
technical procedures required for construction of mutants with
targeted inactivating mutations in specific non-essential genes, or
construction of libraries of mutants with random inactivating
mutations in any non-essential genes. Mutants of interest could
then be placed under BSL3 conditions, and the effects on virulence
of inactivating mutations in individual genes could be tested after
the purine or D-alanine requirement of the parental strain was
eliminated by introduction of an appropriate complementing gene.
Materials and Methods
Bacterial strains, growth conditions, and media
All bacterial strains and plasmids used in this study are listed in
Table 1 and Table 2, respectively, and all primers used for cloning in
this study are listed in Table 3. All primers were purchased from
Integrated DNA Technologies (Coralville, IA). All E. coli strains were
grown in Luria-Bertani (LB) media at 30uCo r3 7 uC as described in
the text. All experiments involving live cultures of B. pseudomallei or B.
mallei were performed in the BSL3 facility at the University of
Colorado School of Medicine. All Burkholderia strains were grown in
LB broth at 37uC unless otherwise stated. Kanamycin, when
appropriate for plasmid selection, was added at a concentration of
50 mg/ml unless otherwise noted. D-alanine, when needed, was
added to LB media at a concentration of 1 mM for experiments with
E. coli and at 10 mM for experiments B. pseudomallei or B. mallei.F o r
resolution of co-integrants by sucrose counter-selection, Burkholderia
co-integrants were grown in YT broth, which was made by dissolving
10 g yeast extract and 10 g tryptone in 1 l of H2Oc o n t a i n i n g1 5 %
sucrose as described by Hamad et al [12].
Analysis of nucleotide and encoded amino acid
sequences of putative alanine racemase genes of B.
pseudomallei and B. mallei
We searched the annotated genomes of B. pseudomallei K96243
and B. mallei ATCC 23344 for previously identified putative
alanine racemase genes. To search for potentially unannotated
alanine racemase genes, we used the nucleotide sequences of the
alr and dadX genes from E. coli strain DH10B [37] in the tBLASTx
program on the NCBI website (http://www.ncbi.nlm.hin.gov) to
probe the sequenced genomes of B. pseudomallei K96243 and B.
mallei ATCC 23344. An analysis of amino acid sequence homology
between the putative alanine racemase proteins encoded by B.
pseudomallei bpsl2179 and bpss0711, B. mallei bma1575, and several
other known alanine racemases was performed using http://www.
ch.embnet.org/software/ClustalW.html.
Construction of the alanine racemase deficient mutant
strain E. coli ALA1
The genome of E. coli has two known alanine racemase genes,
alr and dadX. We obtained the following constructs from Michael
Benedik: a clone of the alr gene designated pET17alr; E. coli
MB1910, an endA derivative of E. coli TG1 with a dadX allele that is
insertionally inactivated by a kanamycin resistance (Km
R)
Table 1. Bacterial strains used in this study.
Strains Relevant features and use Reference
B. pseudomallei K96243 Human Clinical isolate; Km
RGm
RZeo
R Pb
R [35]
B. pseudomallei 1026b Human Clinical isolate; Km
R Gm
R Zeo
R Pb
R [10]
B. mallei ATCC 23344 Human Clinical isolate; Km
S Gm
S Zeo
S Pb
R [62]
B. pseudomallei K96243 Dbpss0711 Unmarked deletion of bpss0711 This study
B. pseudomallei K96243 Dbpsl2179 Unmarked deletion of bpsl2179 This study
B. pseudomallei K96243 Dbpss0711Dbpsl2179 Unmarked deletions of bpss0711 and bpsl2179, D-alanine requiring This study
B. pseudomallei K96243 Dbpss0711Dbpsl2179+pAlr-comp Unmarked deletions of bpss0711 and bpsl2179 carrying complementation
replicating vector pAlr-comp; no D-alanine requirement
This study
B. pseudomallei K96243 Dbpss0711Dbpsl2179DflgK Unmarked deletions of bpss0711, bpsl2179,a n dflgK, D-alanine requiring and
non-motile
This study
B. pseudomallei K96243 Dbpss0711Dbpsl2179DflgK+pAlr-
compflgK
Unmarked deletions of bpss0711, bpsl2179,a n dflgK carrying complementation
replicating vector pAlr-comp flgK;n oD-alanine requirement and motile
This study
B. pseudomallei 1026b Dbpss0711Dbpsl2179 Unmarked deletions of bpss0711 and bpsl2179, D-alanine requiring This study
B. pseudomallei 1026b Dbpss0711Dbpsl2179+pAlr-comp Unmarked deletions of bpss0711 and bpsl2179 carrying complementation
replicating vector pAlr-comp; no D-alanine requirement
This study
B. pseudomallei 1026b Dbpss0711Dbpsl2179DflgK Unmarked deletions of bpss0711, bpsl2179,a n dflgK, D-alanine requiring and
non-motile
This study
B. pseudomallei 1026b Dbpss0711Dbpsl2179DflgK+pAlr-compflgK Unmarked deletions of bpss0711, bpsl2179,a n dflgK carrying complementation
replicating vector pAlr-comp flgK;n oD-alanine requirement and motile
This study
B. mallei ATCC 23344 Dbma1575 Unmarked deletion of bma1575, D-alanine requiring This study
E. coli MB1910 endA derivative of E. coli TG1 with a dadX allele insertionally inactivated by a
kanamycin resistance (Km
R) determinant flanked by frt sites
Michael Benedik
E. coli MB2786 Contains an alr allele insertionally inactivated by a tetracycline resistance (Tc
R)
determinant flanked by frt sites
Michael Benedik
E. coli ALA1 Alanine racemase deficient E. coli strain MB1910 This study
B. mallei ATCC 23344 Dbma1575+pAlr-comp Unmarked deletion of bma1575 carrying complementation replicating vector
pAlr-comp; no D-alanine requirement
This study
doi:10.1371/journal.pone.0021523.t001
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contains an alr allele insertionally inactivated by a tetracycline
resistance (Tc
R) determinant flanked by frt sites. To construct E.
coli ALA1, we first transferred the Tc
R-marked alr allele from
MB2786 into MB1910 by phage P1 transduction and demon-
strated that the resulting transductant was both Km
R and Tc
R and
also able to form colonies on LB agar supplemented with DL-
alanine but not on un-supplemented LB agar, consistent with
inactivation of both alr and dadX. Next, we removed the Km
R and
Tc
R determinants by introducing an Ap
R temperature-sensitive
plasmid pCP20 [56] that encodes flp recombinase, which catalyzes
recombination between the frt sites flanking the Km
R and Tc
R
determinants. To complete the construction of strain ALA1, we
eliminated pCP20 by overnight growth at a non-permissive
temperature (37uC), leaving the alr and dadX alleles with single
inactivating frt sites but without the Tc
R or Km
R determinants.
Complementation of E. coli ALA1 with cloned alanine
racemase genes from B. pseudomallei
We designed the primer pairs BPSL2179F2/BPSL2179R2 and
BPSS0711F/BPSS0711R to PCR amplify bpsl2179 and bpss0711,
respectively, along with their putative promoters. Since the region
of the B. mallei chromosome that contains bma1575 is nearly
identical to the region containing bpsl2179 in B. pseudomallei, the
primer pair BPSL2179F2/BPSL2179R2 was also used to amplify
bma1575 with its putative promoter. Additionally, primer pair
BPSS0711-F2/BPSS0711-R was used to amplify a fragment that
contained a 250 bp longer upstream sequence than that amplified
by primer pair BPSS0711-F/BPSS0711-R. Touchdown PCR was
performed using Ex Taq DNA polymerase as previously described
[12]. PCR amplicons were cloned into pCR2.1-TOPOH using
conditions specified by the manufacturer (Invitrogen, Carlsbad,
CA). The bpsl2179, bpss0711, bpss0711-F2, and bma1575 genes
from these clones were sequenced at the University of Colorado
Cancer Center DNA Sequencing and Analysis Core Facility and
compared with the annotated genome sequence of B. pseudomallei
strain K96243 and B. mallei ATCC 23344, respectively. To assess
the function of the putative alanine racemase proteins encoded by
bpsl2179, bpss0711, and bma1575, we transformed the pCR2.1-
TOPOH-bpsl2179, pCR2.1-TOPOH-bpss0711, pCR2.1-TOPOH-
bpss0711-F2, and pCR2.1-TOPOH-bma1575 clones into E. coli
ALA1 made competent by chemical treatment, as described
previously [57]. E. coli ALA1 transformants containing pCR2.1-
TOPOH -bpsl2179, pCR2.1-TOPOH-bpss0711, pCR2.1-TOPOH-
bpss0711-F2, or pCR2.1-TOPOH-bma1575 were selected on LB
agar without added D-alanine. Representative colonies were
picked and retested for their ability to grow on LB agar with
and without D-alanine at 1 mM.
Construction of alanine racemase deficient mutants of B.
pseudomallei and B. mallei
To generate unmarked, in-frame deletions in the bpsl2179 and
bpss0711 chromosomal genes of B. pseudomallei, we first used PCR
to construct clones with the desired Dbpsl2179 and Dbpss0711
alleles flanked by approximately 1000 bp segments of the
contiguous upstream and downstream flanking regions from the
Table 2. Plasmids used in this study.
Vector Relevant features and use Reference
pET17alr pET17 containing E. coli alr Michael Benedik
pCP20 Encodes flp recombinase [56]
pCR2.1-TOPOH-bpss0711 pCR2.1-TOPOH containing B. pseudomallei bpss0711 This study
pCR2.1-TOPOH-bpss0711-F2 pCR2.1-TOPOH containing B. pseudomallei bpss0711-F2 that has a 250 bp longer upstream sequence
than bpss0711
pCR2.1-TOPOH-bpsl2179 pCR2.1-TOPOH containing B. pseudomallei bpsl2179 This study
pCR2.1-TOPOH-bma1575 pCR2.1-TOPOH containing B. mallei bma1575 This study
pMo130 Suicide vector for allelic exchange in Burkholderia; pUC19 ori, RK2 oriT, xylE, sacB,K m
R, used to construct
pAlr-allex
[12]
pMo146 Source of DflgK [12]
pMo168 Replicative vector for Burkholderia; oripBBR1, mob+, xylE,K m
R, used to construct pAlr [12]
pMo173 Source of flgK for complementation [12]
pAlr-allex Suicide vector for allelic exchange in Burkholderia alr mutants; pUC19 ori, RK2 oriT, xylE, sacB, bpsl2179 This study
pAlr-comp Replicative vector for Burkholderia; oripBBR1, mob+, xylE, bpsl2179 This study
doi:10.1371/journal.pone.0021523.t002
Table 3. Primers used in this study.
Primer name Sequence
BPSS0711-down attcgaggaggacgacatggaccga
BPSS0711-up aacccatgcaacaaagaataggaca
BPSS0711orfdel-F ctcgccccatcgtcgcccgcgcgctcgcccagccggtgcg
BPSS0711orfdel-R cgcaccggctgggcgagcgcgcgggcgacgatggggcgag
BPSS0711-F tgcgcaggtttcgtgcccgc
BPSS0711-R gcgcgtcggacgcggctc
BPSS0711-F2 tgatcggatggtccgggcca
BPSL2179 down accgcgagcagcatcgcgagccggttctgt
BPSL2179 up accgcctgcaggatcgcgccttcggatagc
BPSL2179-down-
HindIII
accgcgagcagcatcgcgagaagcttctgt
BPSL2179F2-2 atgatgaggcagccgacgaccttgatcgaa
BPSL2179orfdel-F cgatttccgccacgatccacgtcgcgccgcgcgtgcccgt
BPSL2179-up-SmaI accgcctgcaggatcccgggttcggatagc
BPSL2179orfdel-R acgggcacgcgcggcgcgacgtggatcgtggcggaaatcg
BPSL2179R2-2 cgatctgcgcgagcgactgcagcagcagcg
Dflgk-US-NheI gtcgtcagtagctagcctcgtcacccgcattctcgatgtcgacg
DflgK-DS-HindIII gtacgatcgacaagcttcggtgcccgcctgcggcgcgggcgtcaccgtg
doi:10.1371/journal.pone.0021523.t003
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constructs separately into the mobilizable suicide vector pMo130,
and we used the resulting clones with previously described allelic
exchange protocols to substitute the Dbpsl2179 and Dbpss0711
alleles for their corresponding wild type alleles in the chromo-
somes of B. pseudomallei strains K96243 and 1026b [12]. In
addition, we used the pMo130 clone carrying Dbpsl2179 with
similar methods to substitute the Dbpsl2179 allele for the wild type
bma1575 allele in B. mallei strain ATCC 23344. This was possible
because the chromosomal region in B. mallei that contains
bma1575 has almost complete nucleotide sequence identity with
the corresponding chromosomal segment from B. pseudomallei
K96243. Additional experimental details are provided in the
following paragraphs.
To construct an in-frame deletion of bpsl2179, we used the
primer pair BPSL2179-up and BPSL2179-orfdelR with chromo-
somal DNA from B. pseudomallei K96243 to PCR amplify a
fragment containing approximately 1000 bp from the upstream
flanking region of bpsl2179 linked to the first 30 bp from the 59
end and the last 30 bp from the 39 end of the bpsl2179 coding
region. We used primers BPSL2179-down and BPSL2179-
orfdelF (which is complementary to BPSL2179-orfdelR) in a
similar manner to PCR amplify a second fragment containing
the first 30 bp from the 59 end and the last 30 bp from the 39
end of the bpsl2179 coding region linked to approximately
1000 bp from the downstream flanking region of bpsl2179.T h e
fragments produced by these first two PCR reactions were then
used as templates in a second PCR with primers BPSL2179-up
and BPSL2179-down to generate Dbpsl2179, an amplicon
containing the 60 nucleotide long, internally in-frame deleted
variant of the bpsl2179 coding sequence flanked by approxi-
mately 1000 bp long wild type upsteam and downstream
sequences. The resulting Dbpsl2179 amplicon was cloned into
pCR2.1-TOPOH, generating pCR2.1-TOPOH-Dbpsl2179.p C R
2.1-TOPOH-Dbpsl2179 was digested with HindIII and XbaIt o
release the Dbpsl2179 fragment, which was Klenow-treated as
described by the manufacturer (Invitrogen, Carlsbad, CA) and
cloned into SmaI digested pMo130 (15). The resulting plasmid
pMo130-Dbpsl2179 was introduced into B. pseudomallei strains
K96243 and 1026b by biparental mating as previously described
[12]. Co-integrants were selected on LB agar containing 100 mg/
ml kanamycin, 10 mM D-alanine, and 50 mg/ml zeocin (to
counterselect the E. coli donor strain). Co-integrants that
expressed the xylE reporter gene from pMo130 were recognized
as yellow colonies after being sprayed with a mist of
pyrocatechol, as previously described [12]. For resolution of
the co-integrants, individual colonies were inoculated into YT
broth, grown for a minimum of 4 hours, diluted, and plated on
YT agar containing 15% sucrose, as previously described [12],
plus 10 mM D-alanine. A similar procedure was also performed
with B. mallei; however, for selection of co-integrants, 50 mg/ml
polymyxin B was used instead of zeocin to counterselect the E.
coli donor.
An in-frame deletion of bpss0711 was constructed in the same
manner as Dbpsl2179; however, primer pair BPSS0711-up and
BPSS0711-orfdelR and primer pair BPSS0711-down and
BPSS0711-orfdelF were used in PCR with chromosomal DNA
to amplify the upstream and downstream fragments linked to the
internally deleted bpss0711 allele, respectively. A second PCR,
using primers BPSS0711-up and BPSS0711-down and the
fragments produced in the first PCR as templates produced
Dbpss0711, which was cloned into pCR2.1-TOPOH. Following
digestion by HindIII and XbaI, the Dbpss0711 fragment was
Klenow-treated as described above and subcloned into SmaI
digested pMo130 (15). The resulting pMo130-Dbpss0711 was then
introduced into the Dbpsl2179 single mutants of B. pseudomallei
K96243 and 1026b, and also into wild type B. mallei ATCC 23344,
by biparental matings, and co-integrants were selected and
resolved as described above. Resolved mutants were tested for
growth on LB agar with and without 10 mM D-alanine to identify
the putative Dbpsl2179/Dbpss0711 double mutants of B. pseudo-
mallei K96243 and 1026b and the putative Dbma1575 single
mutant of B. mallei ATCC 23344, all of which were shown to
require the exogenous D-alanine for growth. Presence of the
Dbpsl2179 and Dbpss0711 alleles in the B. pseudomallei double
mutant, presence of the Dbpsl2179 allele in the B. mallei single
mutant, and absence of the corresponding wild type alleles was
confirmed by PCR tests using either primer sets BPSL2179-up and
BPSL2179-down or BPSS0711-up and BPSS0711 down, as
appropriate.
Complemention tests with alanine racemase deficient
mutants of B. pseudomallei and B. mallei
To perform complementation tests, we first constructed a
derivative of the mobilizable, replication competent plasmid
pMo168 [12] with a copy of bpsl2179 from B. pseudomallei
K96243. Briefly, pMo168 was digested with SpeI and XbaIt o
remove the aphA cassette that confers resistance to kanamycin,
yielding the digested pMo168DaphA fragment. Plasmid pCR2.1-
TOPOH -bpsl2179 was digested with SpeI and XbaI, and the
fragment containing bpsl2179 was ligated with the digested
pMo168DaphA fragment, yielding pALR-comp. The resulting
plasmid was transformed into E. coli ALA1 made competent by
chemical treatment and plated on LB agar to confirm that the
cloned bpsl2179 directed production of active alanine racemase.
Following incubation at 37uC, the resulting colonies were tested to
confirm the presence of pALR-comp, and the bpsl2179 allele from
pALR-comp was sequenced to confirm its identity with the wild
type bpsl2179 allele. Plasmid pALR-comp was then transferred
from E. coli ALA1(pAlr-comp) into the Dbpsl2179/Dbpss0711
double mutants of B. pseudomallei K96243 and 1026b and the
Dbma1575 single mutant of B. mallei ATCC 23344 by triparental
matings with DH5a(pRK2013) [58]. Putative transformants were
selected on LB agar containing 50 mg/ml zeocin for matings with
B. pseudomallei recipients or 50 mg/ml polymyxin B for matings
with B. mallei recipients, and the presence of pALA1 in
transformant colonies was confirmed by spraying them with
pyrocatechol to detect the xylE reporter and sub-culturing them
onto LB agar and LB agar supplemented with 50 mg/ml zeocin or
50 mg/ml polymyxin B to confirm the intrinsic antibiotic
resistance phenotypes of the B. pseudomallei and B. mallei parental
strains, respectively.
Quantitative determination of D-alanine requirement for
growth of alanine racemase deficient mutants of B.
pseudomallei and B. mallei on solid medium
Wild type and isogenic alanine racemase deficient mutant
strains of B. pseudomallei and B. mallei were grown in LB broth
supplemented with 10 mM D-alanine overnight at 37uC. Over-
night cultures were subcultured into LB broth supplemented with
10 mM D-alanine at an initial OD600=0.05 and grown to log
phase (OD600 nm=0.2). Bacteria from log phase cultures were
collected by centrifugation, washed with LB broth, resuspended in
LB broth to the original volume, and inoculated on LB agar
supplemented with 0 mM, 1.25 mM, 2.5 mM, 5 mM, or 10 mM
D-alanine. Plates were incubated at 37uC for 36–48 hours and
growth was observed.
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racemase deficient mutants of B. pseudomallei and
B. mallei in liquid medium
Wild type and isogenic alanine racemase deficient mutant
strains were grown overnight at 37uC in LB containing 10 mM D-
alanine. Cultures were centrifuged, supernatants removed, and the
pellets were washed with LB broth and inoculated at an initial
OD600 nm=0.1 into LB broth with or without 10 mM D-alanine.
Cultures were incubated at 37uC with shaking, and samples were
removed every 30 minutes for the first 4 hours, then hourly up to
7 hours and again at 24 hours for measurement of OD600 nm
and determination of viable counts on LB agar containing 10 mM
D-alanine. To assess the consequences of shorter periods of D-
alanine deprivation, each the alanine racemase deficient mutant
strains of B. pseudomallei and B. mallei was inoculated into replicate
cultures in LB medium without D-alanine as described above, and
at 30 minute intervals from time zero up to 120 minutes D-alanine
at 10 mM was added back to single cultures. During further
incubation, samples were removed from all of the replicate
cultures at 30 minute intervals up to 180 minutes and then at
hourly intervals up to 7 hours for measurements of growth
(OD600 nm) and of viability on LB agar with 10 mM D-alanine.
Isolation of murine peritoneal macrophages
C57BL/6 mice were bred and murine peritoneal macrophages
were prepared under protocols 56409(05)1B and 56410(05)1E,
which were approved on 5/18/10 and 5/5/10, respectively, by
the University of Colorado Denver Animal Care and Use
Committee. Peritoneal macrophages were harvested from mice 4
days after intraperitoneal inoculation of 1 mg/ml sodium
periodate as described [59]. The peritoneal exudate cells were
re-suspended in RPMI 1640 medium (Sigma-Aldrich, St. Louis,
MO) supplemented with 10% heat-inactivated fetal bovine serum
(BioWhittaker, Walkersville, MD), 15 mM Hepes, 2 mM L-
glutamine, 1 mM sodium pyruvate (Sigma-Aldrich), and penicil-
lin/streptomycin at 100 U/ml and 100 mg/ml, respectively
(RPMI
+; Cellgro, Manassas, VA). This medium was supplemented
with D-alanine at 5 mM where specified. The peritoneal exudate
cells were seeded in flat-bottom 96-well plates at a density of 3610
5
cells per well for macrophage killing assays. The macrophages
were selected by adherence after 24 hours of culture at 37uCi na
5% CO2 incubator. Just prior to infection, the macrophages were
washed in pre-warmed RPMI containing 5 mM D-alanine.
Macrophage killing assays
Macrophage killing capacity was assessed by a gentamicin or a
kanamycin protection assay using a modification of a protocol
described for B. mallei [60]. B. mallei strains were grown overnight
in LB and sub-cultured to OD600 nm=0.6 in LB. B. pseudomallei
strains were grown overnight in LB to an OD600 nm=11. The
bacteria were collected by centrifugation and opsonized by
suspending them for 20 minutes at 37uC in RPMI
+ medium
containing 10% normal mouse serum and 5 mM D-alanine. The
opsonized wild type or isogenic alanine racemase deficient strains
of B. mallei and B. pseudomallei were added at a multiplicity of
infection of 200 to macrophage monolayers in RPMI
+ containing
D-alanine at 5 mM, and the infected monolayers were incubated
for 2 hours with the B. mallei strains or for 3 hours with the B.
pseudomallei strains to permit phagocytosis of the opsonized bacteria
by the macrophages [60,61]. Extracellular bacteria were removed
by washing the monolayers with pre-warmed RPMI
+ medium
containing 6 mg/ml of gentamicin for experiments with B.mallei or
250 mg/ml of kanamycin for experiments with B. pseudomallei. After
removal of the extracellular bacteria, the average multiplicity of
infection was determined to be 10. Fresh RPMI
+ medium, with or
without D-alanine at concentrations indicated in the text, and with
6 mg/ml of gentamicin for experiments with B.mallei or 250 mg/ml
of kanamycin for experiments with B. pseudomallei was added to the
monolayers. After incubation for 0 hours, 3 hours, 4 hours, or
5 hours for experiments with B. pseudomallei and 0 hours or 4 hours
for experiments with B. mallei, five replicate cultures of the infected
macrophages were lysed with 1% Triton X-100 in phosphate
buffered saline (PBS), and the numbers of viable intracellular
bacteria were determined by plating on LB agar for the wild type
stains or on LB agar supplemented with 5 mM D-alanine for the
alanine racemase deficient strains. The percent survival was
calculated as (cfu at tn/cfu at t0) 6100.
Electron Microscopy
Following phagocytosis of wild type or isogenic alanine
racemase deficient strains of B. pseudomallei and B. mallei, the
macrophages were plated as previously described [59] at a density
of 4610
5 per chamber of a 8-well Permanox Labtek chamber slide
system (Nalgene Nunc International, Rochester, NY). The cells
were fixed in 2.5% glutaraldehyde in phosphate buffer, pH 7.4.
The specimens were post-fixed in 1% osmium tetraoxide, treated
with uranyl acetate, dehydrated in ascending ethanol series, and
infiltrated with Embed 812. Ultrathin sections were examined for
the presence and morphological integrity of intracellular bacteria
in a FEI Technai 62 electron microscope operated at 80 kV.
Construction and complementation of a B. pseudomallei
flagellar mutant using alanine racemase as the selectable
genetic marker
To demonstrate the utility of alanine racemase as a selection
marker for genetic manipulations in Burkholderia spp., we
constructed the allelic exchange vector pAlr-allex by replacing
aphA of pMo130 [12] with bpsl2179 from B. pseudomallei K96243.
Briefly, pMo130 [12] was digested with SpeI and XbaI to remove
the aphA cassette, yielding the pMo130DaphA fragment. To clone
the wild type bpsl2179 allele into pMo130DaphA, pCR2.1-TOPOH
-bpsl2179 was digested with SpeI and XbaI and the resulting
fragment containing bpsl2179 was ligated with the restriction-
digested pMo130DaphA fragment, yielding pALR-allex. The
pALR-allex plasmid was transformed into chemically competent
alanine racemase deficient E. coli strain ALA1 and plated on LB
agar without added D-alanine. Growth of the transformants at
37uC demonstrated expression of the bpsl2179 gene in pALR-
allex. The presence of pALR-allex in the transformants was
confirmed, and the region flanking bpsl2179 was sequenced to
confirm the predicted nucleotide sequence of the wild type
bpsl2179 allele.
We wished to demonstrate directly that pALR-allex can be used
for allelic exchange protocols in pathogenic Burkholderia spp.
Toward that end, we first subcloned the DflgK allele from pMo146
[12] into pALR-allex. Briefly, we PCR amplified DflgK using
primers Dflgk-US-NheI and DflgK-DS-HindIII, digested the
resulting amplicon with NheI and HindIII, and ligated it with into
linearized pALR-allex generated by treating pALR-allex with NheI
and HindIII. The resulting plasmid, pALR-allexDflgK, was
transformed into E. coli strain ALA1 made competent by chemical
treatment, and transformants were selected by growth on LB agar
without added D-alanine. Next, pALR-allexDflgK was introduced
into the alanine racemase deficient Dbpss0711Dbpsl2179 double
mutants of B. pseudomallei K96243 and B. pseudomallei 1026b by
triparental matings, as described above. Co-integrants were
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resolved co-integrants were subsequently selected by growth on LB
agar containing 15% sucrose plus 10 mM D-alanine. We
determined the DflgK or flgK+ genotype of resolved co-integrants
by screening individual colonies for their non-motile or motile
phenotypes, respectively.
For in-trans complementation of DflgK B. pseudomallei mutants, we
subcloned the wild type flgK gene from pMo173 [12] into the
pALR-comp plasmid described previously. The flgK gene with its
predicted promoter were excised from pMo173 [12] by digestion
with NheI and HindIII and the resulting fragment was ligated into
NheI- and HindIII-digested pALR-comp to generate pALR-comp-
flgK. pALR-comp-flgK was introduced by triparental matings into
the DflgK mutants of B. pseudomallei K96243 and 1026b strains
described above, and the resulting transconjugant colonies were
selected by growth on LB agar with added D-alanine and screened
for restoration of the motile phenotype.
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